Skip to content
Clinical Trials – home
CroatiaBack to Croatia

Clinical trials in Cepin

88 clinical trials in Cepin, Croatia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CroatiaOur site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)
Cepin at a glance
88
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

88 trials in Cepin

Open in trial search

Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:LY4268989 adipic acid
  • Sponsor:Eli Lilly & Co.

Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:SPY001-001
  • Sponsor:Spyre Therapeutics Inc.

Renal disorder

Recruiting

BI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases

Investigational
Countries:CroatiaCroatia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Apecotrep
  • Sponsor:Boehringer Ingelheim Espana S.A.

Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

BI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:BI 3000202
  • Sponsor:Boehringer Ingelheim Espana S.A.

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

A Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:SPY001-001
  • Sponsor:Spyre Therapeutics Inc.

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Crohn's disease

Recruiting

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC

Crohn's disease

Recruiting

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn's Disease

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Eltrekibart
  • Sponsor:Eli Lilly & Co.

Other cities in Croatia

The busiest research cities in the country

All 26 cities in Croatia

Clinical research in Cepin

What the registry says about research in the country

01 Cardiovascular Diseases

Clinical trial activity in Cepin is focused entirely on cardiovascular diseases, with studies exploring new ways to reduce heart-related events and improve long-term outcomes for people living with complex heart conditions.

  • Chronic heart failure
  • Heart failure with mildly reduced or preserved ejection fraction
  • Heart failure with reduced ejection fraction
  • Heart condition

These trials are mainly testing whether newer treatments can better control inflammation, protect the heart, and lower the risk of hospitalization or cardiovascular death.

02 Heart Failure and Inflammation

Several studies are examining heart failure together with systemic inflammation, aiming to see whether targeted therapy can improve outcomes for patients with HFmrEF and HFpEF.

  • HFmrEF
  • HFpEF
  • Systemic inflammation
  • Cardiovascular death and heart failure events

This research is designed to evaluate a potential new treatment approach for people whose heart failure is linked with inflammatory activity.

03 Heart Failure Treatment Options

Another important area of research is the management of heart failure in patients who cannot use standard mineralocorticoid receptor antagonists, with studies looking at both effectiveness and safety.

  • HFrEF
  • Finerenone
  • Safety and tolerability
  • Standard heart failure care

These trials are intended to expand treatment options for people with limited access to current therapies.

04 Diabetes, Hypertension, and Cardiovascular Risk

Research in the city also includes patients with type 2 diabetes, hypertension, and established cardiovascular disease, reflecting the close link between metabolic and heart health.

  • Type 2 diabetes
  • High blood pressure
  • Established cardiovascular disease
  • Heart-related hospital visits

These studies are focused on whether combining therapies can better prevent serious cardiovascular events in high-risk patients.

05 Iron Deficiency in Chronic Heart Failure

One trial is exploring whether treating iron deficiency in people with symptomatic chronic heart failure can improve survival and reduce worsening heart failure.

  • Symptomatic chronic heart failure
  • Iron deficiency
  • Ferric derisomaltose
  • Hospitalization prevention

This line of research aims to clarify the role of iron replacement as part of comprehensive heart failure care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.